Switch to:
More From Other Websites
Halozyme Therapeutics To Present At Upcoming Healthcare Conferences Feb 23 2017
MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 with Halozyme PEGPH20 Feb 13 2017
Halozyme To Host Fourth Quarter 2016 Financial Results Conference Call Feb 01 2017
Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US :... Jan 27 2017
ETFs with exposure to Halozyme Therapeutics, Inc. : January 17, 2017 Jan 17 2017
Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US :... Jan 16 2017
Halozyme Estimates 2017 Revenue of $115M to $130M Jan 11 2017
Why trader is selling Halozyme calls Jan 11 2017
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 10 2017
Halozyme Therapeutics (HALO) in Focus: Stock Up 6.4% Jan 10 2017
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2017
Halozyme Provides Program Updates, 2017 Financial Guidance At 35th Annual JP Morgan Healthcare... Jan 09 2017
Can the Rally in Halozyme (HALO) Shares Continue? Jan 09 2017
Biotech Industry Off to a Strong Start in 2017 Latest Reports on Halozyme Therapeutics and Geron Jan 09 2017
ETFs with exposure to Halozyme Therapeutics, Inc. : January 6, 2017 Jan 06 2017
Company News for January 06, 2017 Jan 06 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK